
Full text loading...
We use cookies to track usage and preferences.I Understand
Human papillomavirus infection, a prevalent global sexually transmitted disease, is linked to various malignancies like cervical cancer, head-and-neck squamous cell carcinoma, and anal cancer. Researchers are actively exploring phytoconstituents from medicinal plants.
This in silico study aims to assess the anti-human papillomavirus capabilities of phytochemical compounds sourced from Ocimum sanctum, Curcuma longa, Nyctanthes arbor-tristis, Zingiber officinale, Andrographis paniculata, Acacia nilotica, Psidium guajava, Ficus religiosa, Emblica officinalis, and Tinospora cordifolia plants.
Through in silico studies, the anti-human papillomavirus capabilities of these compounds were assessed, focusing on their binding affinity to viral E6 protein. Phytochemicals absorption, distribution, metabolism, excretion, and toxicity (ADMET) analysis gauged drug-likeness and toxicity.
Notably, compounds like Tinosporaside, β-sitosterol, β-sitosteryl-D-glucoside, botulin, ∞-amyrin, and ß-amyrin exhibited strong binding affinity.
These findings provide insights for drug design, encouraging further in-vitro and in-vivo analyses.
Article metrics loading...
Full text loading...
References
Data & Media loading...
Supplements